Aminolevulinic Acid Dehydratase (ALAD), Whole Blood
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Confirmation of a diagnosis of aminolevulinic acid dehydratase deficiency porphyria
This test will not detect lead intoxication.
Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request
Aminolevulinic acid dehydratase (ALAD) activity can be inhibited in other situations including hereditary tyrosinemia type 1, lead intoxication, and exposure to styrene, trichloroethylene, or bromobenzene. These causes should be ruled out when considering a diagnosis of ALAD deficiency porphyria.
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
The following algorithms are available in Special Instructions:
-Porphyria (Acute) Testing Algorithm
-Porphyria (Cutaneous) Testing Algorithm
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Enzymatic End point/Spectrofluorometric
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Porphobilinogen (PBG) Synthase
ALAD (Aminolevulinic Acid Dehydratase) Deficiency Porphyria (ADP)